Barratt Developments Appoints Countryside Executive Mike Scott As Executive Director And CFO

Barratt Developments (BDEV.L) said that it has appointed Mike Scott, who is currently the Chief Financial Officer of Countryside Properties, as an Executive Director and Chief Financial Officer. The date he will join Barratt is currently being finalized and will be announced in due course.

Mike Scott joined Countryside as Group Financial Controller in 2014. Prior to joining Countryside, Mike held a number of senior finance roles from 2010 until 2014 at J. Sainsbury Plc, including latterly as Head of Investor Relations. Mike qualified as a chartered accountant with PricewaterhouseCoopers LLP in 2002.

Barratt noted that Jessica White will step down from the Board on 30 June 2021 and thereafter David Thomas, Barratt Group Chief Executive, who previously held the role of Barratt Chief Financial Officer for six years until July 2015, will assume temporary responsibility for the finance function. He will be supported by John Flynn, Group Operations Financial Controller and Jonathan Rumble, Group Financial Controller.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Longmont Colorado -based Royal Crest Dairy is recalling 2% Chocolate Milk citing the potential to be contaminated with undeclared egg, a known allergen, the U.S. Food and Drug Administration said. The recall involves Farmer's 2% Reduced Fat Chocolate Milk Pints with the code date of AUG-22. ANI Pharmaceuticals, Inc. (ANIP) Monday announced a wider loss for the second quarter, despite a 52 percent surge in revenues. For the full year 2022, the company reiterated the adjusted earnings per share range, revenue guidance and raised Cortrophin revenue outlook. The company reported a quarterly... Shares of BioNTech SE were losing around 4 percent in the morning trading in Germany and around 5 percent in the pre-market activity on Nasdaq after the German Covid-19 vaccine maker reported sharp drop in profit and revenues for the second quarter. However, the company recorded strong growth in first-half results. Further, the company maintained BioNTech COVID-19 vaccine revenue guidance
Follow RTT